Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 9.58% is 79% below its 5-year average of 45.93%, near the low end of its 5-year range (0.95%–263.62%).
As of the fiscal period ended Wednesday, December 31, 2025. 21.52% above its 12-month average of 7.88%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 9.58%.
DEBT TO ASSETS RATIO
9.58%
DEBT TO ASSETS RATIO AVG TTM
7.88%
DEBT TO ASSETS RATIO AVG 3Y
6.85%
DEBT TO ASSETS RATIO AVG 5Y
45.93%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+21.52%
CURRENT VS 3Y AVG
+39.76%
CURRENT VS 5Y AVG
-79.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+8606.37%
vs the sector median at left
Apollomics, Inc.
Market Cap
$50.51M
Debt to Assets Ratio
9.58%
TTM Avg
7.88%
3Y Avg
6.85%
5Y Avg
45.93%
Market Cap
$50.25M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$51.12M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.95M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apollomics, Inc. (APLM) | $50.51M | 9.58% | 7.88% | 6.85% | 45.93% |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | 0.03% | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.96M | 0.97% | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.14% | N/A | N/A | N/A |
| Celularity Inc. (CELU)vs › | $49.50M | 0.61% | N/A | N/A | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.58M | 0.05% | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $49.40M | 1.26% | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.95M | 0.00% | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $53.01M | 0.01% | N/A | N/A | N/A |
Debt/Assets
9.6%
Debt/Equity
N/A
Current Ratio
0.96
Interest Coverage
-145.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2025-12-31 | 9.58% |
| 2025-06-30 | 6.69% |
| 2024-12-31 | 7.38% |
| 2024-06-30 | 13.66% |
| 2023-12-31 | 8.42% |
| 2023-06-30 | 0.95% |
| 2022-12-31 | 1.30% |
| 2022-06-30 | 1.35% |
| 2021-12-31 | 263.62% |
| 2021-06-30 | 21.90% |
| 2020-12-31 | 170.39% |
| 2019-12-31 | 171.99% |
